NO954544L - Stabile flytende preparater av gamma-interferon - Google Patents

Stabile flytende preparater av gamma-interferon

Info

Publication number
NO954544L
NO954544L NO954544A NO954544A NO954544L NO 954544 L NO954544 L NO 954544L NO 954544 A NO954544 A NO 954544A NO 954544 A NO954544 A NO 954544A NO 954544 L NO954544 L NO 954544L
Authority
NO
Norway
Prior art keywords
stable liquid
gamma
liquid preparations
gamma interferon
ifn
Prior art date
Application number
NO954544A
Other languages
English (en)
Other versions
NO320069B1 (no
NO954544D0 (no
Inventor
Tue Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO954544L publication Critical patent/NO954544L/no
Publication of NO954544D0 publication Critical patent/NO954544D0/no
Publication of NO320069B1 publication Critical patent/NO320069B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO19954544A 1993-05-12 1995-11-10 Stabile, vandige, farmasoytiske preparater av gamma-interferon, beholdere som inneholder slike, fremgangsmate for stabilisering av gamma-interferon i slike preparater, samt aerosolpartikler for anvendelse i terapi ved inhalasjon. NO320069B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6032793A 1993-05-12 1993-05-12
PCT/US1994/004928 WO1994026302A1 (en) 1993-05-12 1994-05-04 Stable liquid compositions of gamma interferon

Publications (3)

Publication Number Publication Date
NO954544L true NO954544L (no) 1995-11-10
NO954544D0 NO954544D0 (no) 1995-11-10
NO320069B1 NO320069B1 (no) 2005-10-17

Family

ID=22028807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954544A NO320069B1 (no) 1993-05-12 1995-11-10 Stabile, vandige, farmasoytiske preparater av gamma-interferon, beholdere som inneholder slike, fremgangsmate for stabilisering av gamma-interferon i slike preparater, samt aerosolpartikler for anvendelse i terapi ved inhalasjon.

Country Status (23)

Country Link
EP (1) EP0697887B1 (no)
JP (1) JP4053586B2 (no)
KR (1) KR100330325B1 (no)
CN (1) CN1120724C (no)
AT (1) ATE173632T1 (no)
AU (1) AU683469B2 (no)
CA (1) CA2159602C (no)
CZ (1) CZ285389B6 (no)
DE (1) DE69414841T2 (no)
DK (1) DK0697887T3 (no)
ES (1) ES2126114T3 (no)
FI (1) FI111442B (no)
GR (1) GR3029286T3 (no)
HK (1) HK1008303A1 (no)
HU (1) HUT72980A (no)
IL (1) IL109350A (no)
NO (1) NO320069B1 (no)
NZ (1) NZ266354A (no)
PL (1) PL176079B1 (no)
SK (1) SK280958B6 (no)
TW (1) TW275585B (no)
WO (1) WO1994026302A1 (no)
ZA (1) ZA942955B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2758154B2 (ja) * 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
ATE255903T1 (de) * 1995-11-07 2003-12-15 Genentech Inc Stabilisierende formulierung für ngf
JP3493866B2 (ja) * 1995-12-27 2004-02-03 ライオン株式会社 発泡性口腔用組成物
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
JP2000516210A (ja) 1996-07-12 2000-12-05 ロイコサイト，インコーポレーテッド ケモカインレセプターアンタゴニストとその使用方法
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
SK284989B6 (sk) * 1996-12-24 2006-04-06 Biogen, Inc. Kvapalná kompozícia obsahujúca interferón a spôsob stabilizácie interferónu
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US7070799B1 (en) 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO2001072278A2 (en) * 2000-03-30 2001-10-04 Generex Pharmaceuticals Inc. Method for administering insulin to the buccal region
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
JP5052736B2 (ja) * 2001-05-30 2012-10-17 中外製薬株式会社 タンパク質製剤
EP1516627A1 (en) * 2003-09-17 2005-03-23 CONARIS research institute AG Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
JP5137055B2 (ja) * 2006-03-10 2013-02-06 塩野義製薬株式会社 安定化されたインターフェロン−γ組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE76311T1 (de) * 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation

Also Published As

Publication number Publication date
NZ266354A (en) 1997-06-24
ES2126114T3 (es) 1999-03-16
FI955136A (fi) 1995-10-27
CN1122575A (zh) 1996-05-15
ATE173632T1 (de) 1998-12-15
CA2159602C (en) 2008-08-26
JP4053586B2 (ja) 2008-02-27
HUT72980A (en) 1996-06-28
WO1994026302A1 (en) 1994-11-24
AU6782294A (en) 1994-12-12
DE69414841D1 (de) 1999-01-07
FI111442B (fi) 2003-07-31
FI955136A0 (fi) 1995-10-27
EP0697887A1 (en) 1996-02-28
IL109350A (en) 2001-01-28
IL109350A0 (en) 1994-07-31
SK280958B6 (sk) 2000-10-09
CN1120724C (zh) 2003-09-10
AU683469B2 (en) 1997-11-13
HK1008303A1 (en) 1999-05-07
CZ285389B6 (cs) 1999-07-14
KR960702320A (ko) 1996-04-27
TW275585B (no) 1996-05-11
ZA942955B (en) 1995-10-30
CA2159602A1 (en) 1994-11-24
GR3029286T3 (en) 1999-05-28
DE69414841T2 (de) 1999-06-02
EP0697887B1 (en) 1998-11-25
CZ295595A3 (en) 1996-04-17
SK137895A3 (en) 1997-02-05
DK0697887T3 (da) 1999-08-09
NO320069B1 (no) 2005-10-17
PL311639A1 (en) 1996-03-04
KR100330325B1 (ko) 2002-11-01
HU9503223D0 (en) 1996-01-29
JPH08510242A (ja) 1996-10-29
NO954544D0 (no) 1995-11-10
PL176079B1 (pl) 1999-04-30

Similar Documents

Publication Publication Date Title
NO954544D0 (no) Stabile flytende preparater av gamma-interferon
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
IL103510A0 (en) Pharmaceutical compositions containing antibodies for causing immunosuppression
HU9203871D0 (en) Pharmaceutical application of certain cistine derivatives
ES479423A1 (es) Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina.
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
WO2001018039A3 (en) INCREASED PRODUCTION OF INTERFERON-$g(a)
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
ITMI913306A1 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.
ITRM920551A1 (it) Composizioni farmaceutiche somministrabili per via intranasale contenenti calcitonina quale principio attivo.
ITMI920214A0 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
ITRM910191A1 (it) Composizione farmaceutica liquida per somministrazione endonasale.
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
DK36290A (da) Nitroolefiner, praeparater indeholdende dem samt anvendelse af dem til fremstilling af farmaceutiske praeparater
IT8224219A0 (it) Composizione farmaceutica per la somministrazione orale di calcitonina.
IT9021264A0 (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina

Legal Events

Date Code Title Description
MK1K Patent expired